Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab + Chemoradiation in Locally Advanced Esophageal Cancer
NCT00109850Phase 2Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- May 2005
- Primary completion
- Sep 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in esophageal cancer, sponsored by SWOG Cancer Research Network. Started May 2005; status: terminated.
02
Drugs
KL-140
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00109850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109850.